FDA Inspection
Taejoon Pharmaceutical Co., Ltd.Taejoon Pharmaceutical Co., Ltd. – FDA Inspection, Sep 18, 2018
Record Details
This FDA Inspection record concerns Taejoon Pharmaceutical Co., Ltd., with an inspection on September 18, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Dennis Cantellops Paite (Issuing Officer)
- Diane Goll (Issuing Officer)
View Company Profile
ID · 569c59be-c649-423f-a634-ee895f7102fc
Inspection Facts
- Inspection number
- 1068405
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Taejoon Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 15, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 15, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taejoon Pharmaceutical Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.